Excited to share our new paper in JCO Global Oncology! It highlights critical issues surrounding the accessibility and affordability of global oncology conferences for young oncologists and researchers from #LMICs. Union for International #CancerControl OncoAlert ASCO Common Sense Oncology AORTIC ascopubs.org/doi/10.1200/GO…

Important work by Khalid El Bairi, MD et al. Highlighting global inequities for oncologists and researchers from #LMICs at conferences @paimadhu was just highlighting this. Another example unfortunately, this time in oncology 😣 What can we do to change this?

Seriously. I actually don’t love these “global” conferences - I will gladly stay home to boycot 💅🏻

I had the privilege of delivering a workshop on research integrity to young doctors and students at the University of Lusaka in Zambia during the 6th Annual Medical Research and Mentorship Symposium focusing on providing early exposure to methdology and mentorship POHER

Zambia has also wonderful coffee ! Try it if you are visiting this beautiful country POHER Akwi Asombang MD MPH Zambia

The content of predatory journals may be used in evidence synthesis potentially compromising guideline development in clinical practice and harming patients. This critical issue was the focus of a plenary conference I delivered during the Annual Meeting of the POHER

Instead of scores, a framework might better assess trial results, helping you improve your skills to do it yourself! Check out our THEOREMM proposal: onlinelibrary.wiley.com/doi/full/10.11… Improving your ability to appraise evidence is KEY. VKPrasadLab Vinay Prasad MD MPH theoremm.com

New Shiny App❗️ timotheeolivier-research.com/reverse-km this App provides a reverse KM analysis of selected trials. Basically every event becomes a "censored" and vice-versa. If the output is "statistically significant", you should suspect informative censoring! Check it out!

Yesterday, I posted about collecting together all the 'academic investigators' I knew about. Thank you for the responses, corrections and suggestions. Here is an updated version. Still WIP, but getting there. More soon, including all the social media links. More feedback

Dear HOFN friends, We would greatly appreciate your participation in this survey to understand how oncology guidelines are implemented in High Income Countries vs LMIC. It will take <5 min & responses are confidential. Thank you for your support!  forms.office.com/r/36zG6HfgYY

THE CONQUER STUDY We, the ASCO IDEA Awardees 2024 are conducting a worldwide survey on the use of oncology guidelines. Please help us fill our survey for us to share the results in #ASCO2025 forms.office.com/r/36zG6HfgYY Julie Gralow G Curigliano MD PhD Sara Tolaney OncoAlert Stephanie Graff, MD, FACP, FASCO Tatiana Prowell, MD

These last 2 months have been our milestone months. We have published some- in my opinion- really important pieces. Since there are many new followers, I want to summarize here our major publications from last 2 months that I hope everyone reads- 1. How much did public funds

😬 Another article attempting to argue HRs are too challenging to interpret and we should replace with RMST 😬 redjournal.org/article/S0360-…

This is how corruption is rationalized The truth is doctors who take payments have been shown in meta analysis to be more likely to prescribe low value treatments. I stand by my statement.

Our new paper w/ Vinay Prasad MD MPH is out in JCP today! 19th St Gallen starts in 3 days! Couldn't be more timely! A hot Q was raised at 18th Conf – likely a similar Q will come up again: "Should we combine adjuvant drugs that were tested in isolation in phase 3 trials?" 🧵1/9

In this new paper from CSO group led by Elizabeth Eisenhauer , we provide a checklist for the Discussants of clinical trials at major cancer meetings to use to correctly and critically appraise the trials for the audience. We strongly encourage all organizers and planners of cancer

I'll be presenting on research integrity and gender equity in oncology at #ASCO25 ! See you in Chicago ! ASCO OncoAlert ASCO TECAG OncoDaily

If you're attending #ASCO25 this week, don't forget to check out our poster, which highlights an important topic of research integrity in global oncology #ASCO2025 OncoDaily ASCO ascopubs.org/doi/abs/10.120…

💡New in JCP with Ariadna Tibau Martorell Aaron Kesselheim We find the time for U.S. FDA oncology indications to achieve conversion to regular approval or be withdrawn has shortened. Also, prop of confirmatory studies underway at the time of approval has increased. sciencedirect.com/science/articl…

When African doctors + nurses find fixes that keep patients in care, the world should know. The new #AORTICJournal will publish African evidence, for Africa first, so our solutions are seen, cited & acted on. → tinyurl.com/AORTICAfricaJo… #KeepingAbreastWithDrMiriam AORTIC